Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated at Piper Sandler
Piper Sandler assumed coverage on shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) in a report published on Wednesday morning, MarketBeat.com reports. The firm issued an overweight rating and a $12.00 target price on the stock. Several other equities analysts have also issued reports on the company. HC Wainwright reiterated a “buy” rating and issued […]
Piper Sandler assumed coverage on shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) in a report published on Wednesday morning, MarketBeat.com reports. The firm issued an overweight rating and a $12.00 target price on the stock. Several other equities analysts have also issued reports on the company. HC Wainwright reiterated a “buy” rating and issued […]
